Low-grade sarcoma of the cervix: an unusual diagnosis
Journal: Advances in Medicine and Engineering Interdisciplinary Research DOI: 10.32629/ameir.v3i3.4718
Abstract
Introduction: low-grade endometrial stromal sarcoma is a tumor that represents less than one percent of all uterine malignancies. It is mostly diagnosed between 40 and 55 years of age, it has slow growth, with extrauterine dissemination in 40 and up to 50% of cases at the time of diagnosis. Patient information: 72-year-old woman, with a history of high blood pressure, type 2 diabetes mellitus and surgery for fibroid, along with necrobiosis, who had to undergo total abdominal hysterectomy with double adnexectomy. As a result of the biopsy, submucosal and subserosal intramural leiomyomas with areas of necrosis and hemorrhages were detected. Subsequently, in August 2022, she presented scant bleeding, so she was sent to the Neck Pathology Consultation. She underwent video colposcopy with an exophytic lesion in the vaginal vault. The patient returned to the center due to a tumor measuring ±6 to 8 cm, violaceous, protruding through the vulvar introitus, coming from the vaginal vault and accompanied by bleeding, and friable. The biopsy result determined a low-grade sarcoma-type malignant mesenchymal tumor with two foci of necrosis. Conclusions: uterine cancer is the most common gynecological malignancy. On the other hand, low-grade endometrial stromal sarcoma is a very unusual tumor that ranks second among uterine mesenchymal tumors.
Keywords
uterine cervical neoplasms; diagnosis differential; biopsy
Full Text
PDF - Viewed/Downloaded: 0 TimesReferences
[1] Bhatla N, Aoki D, Sharma DN, Sankaranarayanan R. Cancer of the cervix uteri: 2021 update. Int J Gynaecol Obstet [Internet]. 2021 [citado 05/02/2023];155(Suppl. 1): 28-44.
Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9298213/1. . https://doi.org/10.1002/ijgo.13865.
[2] Doorbar J, Griffin H. Refining our understanding of cervical neoplasia and its cellular origins. Papillomavirus Res [Internet]. 2019 [citado 12/02/2023];7:176-179.
Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6477515/2. https://doi.org/10.1016/j.pvr.2019.04.005.
[3] Siegel RL, Miller KD, Wagle NS, Jemal A. Cancer statistics, 2023. CA Cancer J Clin [Internet]. 2023 [citado 10/03/2023];73(1):17-48.
Disponible en: https://pubmed.ncbi.nlm.nih.gov/36633525/3 . https://doi.org/10.3322/caac.21763.
[4] de Almeida BC, Gonzalez dos Anjos L, Senos Dobroff A, Chada Baracat E, Yang Q, Al-Hendy A, et al. Epigenetic Features in Uterine Leiomyosarcoma and Endometrial Stromal Sarcomas: An Overview of the Literature. Biomedicines [Internet]. 2022 [citado 16/02/2023];10(10):2567.
Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9599831/4. https://doi.org/10.3390/biomedicines10102567.
[5] Rakesh A, Singh P, Shankar A, Ranjan R. Management for a Rare Occurrence of Low Grade Endometrial Stromal Sarcoma (LGESS): A Case Report and Literature Review. IJIRMS [Internet]. 2022 [citado 19/02/2023];7(07):380-383. Disponible en: https://ijirms.in/index.php/ijirms/article/view/14545. https://doi.org/10.23958/ijirms/vol07-i07/1454.
[6] Dai Q, Xu B, Wu H, You Y, Wu M, Li L. The prognosis of recurrent low-grade endometrial stromal sarcoma: a retrospective cohort study. Orphanet J Rare Dis [Internet]. 2021 [citado 22/02/2023];16(1):160. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8028754/6. https://doi.org/10.1186/s13023-021-01802-8.
[7]Gangireddy M, Chan Gomez J, Kanderi T, Joseph M, Kundoor V. Recurrence of Endometrial Stromal Sarcoma, Two Decades Post-Treatment. Cureus [Internet]. 2020 [citado 28/02/2023];12(7):e9249.
Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7430693/7. https://doi.org/10.7759/cureus.9249.
[8] Suzuki A, Aoki M, Miyagawa C, Murakami K, Takaya H, Kotani Y, et al. Differential Diagnosis of Uterine Leiomyoma and Uterine Sarcoma Using Magnetic Resonance Images: A Literature Review. Healthcare [Internet]. 2019 [citado 02/03/2023];7(4):158.
Disponible en: https://www.mdpi.com/2227-9032/7/4/1588. https://doi.org/10.3390/healthcare7040158.
[9] Ichimura T, Kasai M, Imai K, Yamauchi M, Fukuda T, Yasui T, et al. A difficult to diagnose case of low-grade endometrial stromal sarcoma with smooth muscle differentiation treated with laparoscopic surgery: A case report. Mol Clin Oncol [Internet]. 2022 [citado 07/03/2023];16(4):92. Disponible en: https://www.spandidos-publications.com/10.3892/mco.2022.25259. https://doi.org/10.3892/mco.2022.2525.
[10] Rizzo A, Pantaleo MA, Saponara M, Nannini M. Current status of the adjuvant therapy in uterine sarcoma: A literature review. World J Clin Cases [Internet]. 2019 [citado 12/03/2023];7(14):1753-1763. Disponible en: https://www.wjgnet.com/2307-8960/full/v7/i14/1753.htm10. https://doi.org/10.12998/wjcc.v7.i14.1753.
[11] Kim GW, Baek SK, Han JJ, Kim HJ, Sung JY, Maeng CH. Pulmonary Metastasizing Low-Grade Endometrial Stromal Sarcoma: Case Report and Review of Diagnostic Pitfalls. Diagnostics [Internet]. 2022
[citado 10/03/2023];12(2):271.
Disponible en: https://www.mdpi.com/2075-4418/12/2/27111. https://doi.org/10.3390/diagnostics12020271.
[12] Ghirardi V, Bizzarri N, Guida F, Vascone C, Costantini B, Scambia G, et al. Role of surgery in gynaecological sarcomas. Oncotarget [Internet]. 2019 [citado 14/03/2023];10:2561-2575.
Disponible en: https://www.oncotarget.com/article/26803/text/12. https://doi.org/10.18632/oncotarget.26803.
Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9298213/1. . https://doi.org/10.1002/ijgo.13865.
[2] Doorbar J, Griffin H. Refining our understanding of cervical neoplasia and its cellular origins. Papillomavirus Res [Internet]. 2019 [citado 12/02/2023];7:176-179.
Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6477515/2. https://doi.org/10.1016/j.pvr.2019.04.005.
[3] Siegel RL, Miller KD, Wagle NS, Jemal A. Cancer statistics, 2023. CA Cancer J Clin [Internet]. 2023 [citado 10/03/2023];73(1):17-48.
Disponible en: https://pubmed.ncbi.nlm.nih.gov/36633525/3 . https://doi.org/10.3322/caac.21763.
[4] de Almeida BC, Gonzalez dos Anjos L, Senos Dobroff A, Chada Baracat E, Yang Q, Al-Hendy A, et al. Epigenetic Features in Uterine Leiomyosarcoma and Endometrial Stromal Sarcomas: An Overview of the Literature. Biomedicines [Internet]. 2022 [citado 16/02/2023];10(10):2567.
Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9599831/4. https://doi.org/10.3390/biomedicines10102567.
[5] Rakesh A, Singh P, Shankar A, Ranjan R. Management for a Rare Occurrence of Low Grade Endometrial Stromal Sarcoma (LGESS): A Case Report and Literature Review. IJIRMS [Internet]. 2022 [citado 19/02/2023];7(07):380-383. Disponible en: https://ijirms.in/index.php/ijirms/article/view/14545. https://doi.org/10.23958/ijirms/vol07-i07/1454.
[6] Dai Q, Xu B, Wu H, You Y, Wu M, Li L. The prognosis of recurrent low-grade endometrial stromal sarcoma: a retrospective cohort study. Orphanet J Rare Dis [Internet]. 2021 [citado 22/02/2023];16(1):160. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8028754/6. https://doi.org/10.1186/s13023-021-01802-8.
[7]Gangireddy M, Chan Gomez J, Kanderi T, Joseph M, Kundoor V. Recurrence of Endometrial Stromal Sarcoma, Two Decades Post-Treatment. Cureus [Internet]. 2020 [citado 28/02/2023];12(7):e9249.
Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7430693/7. https://doi.org/10.7759/cureus.9249.
[8] Suzuki A, Aoki M, Miyagawa C, Murakami K, Takaya H, Kotani Y, et al. Differential Diagnosis of Uterine Leiomyoma and Uterine Sarcoma Using Magnetic Resonance Images: A Literature Review. Healthcare [Internet]. 2019 [citado 02/03/2023];7(4):158.
Disponible en: https://www.mdpi.com/2227-9032/7/4/1588. https://doi.org/10.3390/healthcare7040158.
[9] Ichimura T, Kasai M, Imai K, Yamauchi M, Fukuda T, Yasui T, et al. A difficult to diagnose case of low-grade endometrial stromal sarcoma with smooth muscle differentiation treated with laparoscopic surgery: A case report. Mol Clin Oncol [Internet]. 2022 [citado 07/03/2023];16(4):92. Disponible en: https://www.spandidos-publications.com/10.3892/mco.2022.25259. https://doi.org/10.3892/mco.2022.2525.
[10] Rizzo A, Pantaleo MA, Saponara M, Nannini M. Current status of the adjuvant therapy in uterine sarcoma: A literature review. World J Clin Cases [Internet]. 2019 [citado 12/03/2023];7(14):1753-1763. Disponible en: https://www.wjgnet.com/2307-8960/full/v7/i14/1753.htm10. https://doi.org/10.12998/wjcc.v7.i14.1753.
[11] Kim GW, Baek SK, Han JJ, Kim HJ, Sung JY, Maeng CH. Pulmonary Metastasizing Low-Grade Endometrial Stromal Sarcoma: Case Report and Review of Diagnostic Pitfalls. Diagnostics [Internet]. 2022
[citado 10/03/2023];12(2):271.
Disponible en: https://www.mdpi.com/2075-4418/12/2/27111. https://doi.org/10.3390/diagnostics12020271.
[12] Ghirardi V, Bizzarri N, Guida F, Vascone C, Costantini B, Scambia G, et al. Role of surgery in gynaecological sarcomas. Oncotarget [Internet]. 2019 [citado 14/03/2023];10:2561-2575.
Disponible en: https://www.oncotarget.com/article/26803/text/12. https://doi.org/10.18632/oncotarget.26803.
Copyright © 2026 Maurice José González Basulto, Gustavo de Jesús Crespo Campo, Dayan Cervantes Peláez
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License